FDA Inspection 1031888 — Thomas Linde, MD

Thomas Linde, MD — FEI 3013599015

The FDA completed an inspection of Thomas Linde, MD on Oct 19, 2017 in Halle (Saale). The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 19, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Halle (Saale) (Germany)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.